When the Food and Drug Administration (FDA), manufacturers, or other agencies issue recalls or warnings about health care products, medical practices must respond carefully to manage risk and protect patients. Such notices can affect a range of products, including drugs, devices, and instruments used in patient care.
Medical providers are advised to seek legal counsel when necessary to clarify their responsibilities during these situations. They should always rely on the most recent information from agencies or manufacturers. Recalls and warnings typically include guidance on minimizing risks for patients, steps for correcting or removing affected products, recommendations for monitoring patients, and information about available alternatives.
Providers are expected to follow manufacturer instructions precisely and document every step taken. If it is not possible to follow recommended actions, they should record the reasons why. Documentation should also be included in individual patient records. If a patient refuses recommended actions, this informed refusal must be noted.
Manufacturers often assign the responsibility of notifying and counseling patients to licensed health care providers. As stated in typical recall language: “[Manufacturer’s name] will not communicate with patients directly about this issue. If patients have been impacted as part of this issue, health care providers have the responsibility to inform patients and/or update a patient’s care pathway.”
Health professionals are encouraged to use resources such as electronic health records (EHR) to identify all affected patients—especially if they prescribed the product or performed procedures involving it. For over-the-counter medications not prescribed by the provider, obligations may be less extensive.
Efforts should be made to contact affected patients at least twice using multiple methods such as phone calls or emails. In serious cases, sending a letter with return receipt requested is suggested for documentation purposes.
Because recalls can generate high volumes of patient inquiries, practices should designate an informed staff member to handle questions and provide accurate guidance. Having a prepared script may help streamline communication. All interactions with patients regarding recalls should be documented.
Financial responsibility for follow-up actions varies by case; sometimes insurers or manufacturers will cover costs related to recall management, while in other cases patients may need to seek reimbursement themselves.
In potential legal proceedings against manufacturers responsible for harm caused by recalled products, facilities and health professionals can reduce their liability by thoroughly documenting compliance with recall protocols. Legal claims generally target manufacturers rather than providers but depend on specific facts of each case.
Healthcare professionals who wish to receive FDA safety alerts can subscribe through the FDA MedWatch program at www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/subscribe-medwatch-safety-alerts.
